RMD — RESMED INC

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 943819 ·
Last close
$222.00
Market Cap
$32.02B
52W High
$281.89
52W Low
$179.75
ADV30
1,349,633
Next earnings
2026-10-29

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — — — —
Mar 2026 1,431,406,000 890,979,000 499,810,000 398,732,000 8,784,285,000 1,660,513,000 2,292,374,000
Dec 2025 1,422,808,000 878,724,000 497,595,000 392,593,000 8,503,370,000 1,417,069,000 2,182,491,000
Sep 2025 1,335,582,000 820,820,000 462,347,000 348,536,000 8,308,352,000 1,383,848,000 2,187,088,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,889,964,000
Investing CF
$-295,261,000
Financing CF
$-907,752,000
CapEx
$-153,701,000
Dividends Paid
$-340,162,000
Buybacks
$-600,045,000
EPS Diluted TTM
$10.43
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$6,958,779,000
Inventory
$911,876,000
Receivables
$1,045,943,000
ST Investments
—
EBIT TTM
$1,916,323,000
Pretax Income TTM
$1,903,306,000
Interest Exp TTM
—
Analysts
15

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,653,443,072
EBITDA
$2,095,774,976
Free Cash Flow
$939,248,256
Enterprise Value
$30,842,636,288
Total Cash
$1,469,234,048
Total Debt
$825,918,976
Shares Out
144,252,306
Trailing EPS
$10.43
Book Value
$45.66
ROE
24.3%
ROA
14.0%
Div Yield
1.21%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 5,653,443,000 1,908,460,000 1,523,293,000 8,965,950,000 2,380,557,000 6,585,393,000 1,805,829,000
Jun 2025 5,146,327,000 1,685,363,000 1,400,723,000 8,174,391,000 2,206,532,000 5,967,859,000 1,751,588,000
Jun 2024 4,685,297,000 1,384,121,000 1,020,951,000 6,872,394,000 2,008,351,000 4,864,043,000 1,401,260,000
Jun 2023 4,222,993,000 1,151,997,000 897,556,000 6,751,708,000 2,621,805,000 4,129,903,000 693,299,000
Jun 2022 — — — — — — —

TTM Snapshot

Revenues TTM
$4,977,432,000
NetIncome TTM
$1,331,066,000
OpCashFlow TTM
$0
Assets (Latest)
$8,174,391,000
Forward EPS
$13.22

Max Pain — expiry 2027-01-15

max pain strike: $230.00 · spot: $222.00 · call oi: 2,333 · put oi: 11,205
Expected Move to 2027-01-15: ±$33.50 (15.09%) — implied range $188.50 – $255.50 · ATM straddle on $220.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
DXCM DEXCOM INC $32.69B $86.62 —
FSNUF Fresenius SE & Co. KGaA $30.61B $54.35 —
MDLN Medline Inc. $30.44B $34.70 —
GEHC GE HealthCare Technologies Inc. $30.10B $66.63 —
FSNUY Fresenius SE & Co. KGaA $29.92B $13.28 —

News headlines (Yahoo Finance, 1h cache)

ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
2026-09-21 20:02 · Yahoo
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
2026-09-19 08:18 · Yahoo
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
2026-09-15 20:07 · Yahoo
This Analyst Just Upgraded ResMed Stock. Here's Why.
2026-09-15 19:57 · Yahoo
Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)?
2026-09-15 17:11 · Yahoo
ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says
2026-09-15 15:00 · Yahoo
Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest
2026-09-14 19:15 · Yahoo
ResMed Stock: Is RMD Underperforming the Healthcare Sector?
2026-09-14 13:07 · Yahoo
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
2026-08-27 20:05 · Yahoo
ResMed Stock: Analyst Estimates & Ratings
2026-08-25 14:51 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.